Logo Medical XPRT
Companies
Products
Services
Software
Training
Applications
Sign in
List your business

Advertising options
  1. Home
  2. News
  3. hospital research
Show results for
Products
Services
Software
Applications

Companies

News
Articles
Downloads
Videos

Refine by
Date

  • Older

Hospital Research Articles & Analysis

99 news found

SeqOne Genomics appoints Hervé Pouzoullic as Chief Commercial Officer

SeqOne Genomics appoints Hervé Pouzoullic as Chief Commercial Officer

Its solution is relied upon by a growing number of hospitals and private medical laboratories, as well as for biopharmas seeking to harness the potential of genomics in drug discovery. ...

BySeqOne S.A.S.


How Great Clinical Trial Managers Stand Out From The Rest

How Great Clinical Trial Managers Stand Out From The Rest

This job is undeniably rewarding but requires a high level of expertise and a knack for research. A clinical trial manager is responsible for many tasks, including overseeing everything from creating a valid test to its administration, recruitment, logistics, and follow-up. ...

ByBrio Group


Lynx Bio Makes Headway on New Diagnostic for Blood Cancer Drugs

Lynx Bio Makes Headway on New Diagnostic for Blood Cancer Drugs

In 2009, as a graduate student at the University of Wisconsin-Madison, Chorom Pak was part of a group of researchers working to understand how sensitive patients’ cells were to certain therapies for blood cancers, such as multiple myeloma. The group, which also included UW-Madison professors Shigeki Miyamoto and David Beebe, and postdoctoral fellow Edmond ...

ByLynx Biosciences, Inc.


Combines mesenchymal stem-cell-based product, with Kurve’s intranasal drug delivery technology

Combines mesenchymal stem-cell-based product, with Kurve’s intranasal drug delivery technology

The product has been administered to patients intravenously in collaboration with Hospital Infantil Universitario Niño Jesús in Madrid, Spain. The production is performed at the hospital utilizing the Orgenesis Mobile Processing Units and Lab (OMPUL) to supply clinical grade batches. ...

ByKurve Therapeutics, Inc.


Exclusive License Agreement With Case Western Reserve University for Core-NK Platform

Exclusive License Agreement With Case Western Reserve University for Core-NK Platform

Under the agreement, Chimeric gains exclusive global rights to the CORE-NK platform for oncology, where Chimeric and CWRU are currently advancing multiple product candidates in Dr Wald’s laboratory under the recently announced Sponsored Research Agreement. Chimeric also receives exclusive global rights to the CORE-NK platform for immune disorders and viral infectious ...

ByChimeric Therapeutics


Kephera Diagnostics receives $417,074 grant award from the Massachusetts Life Sciences Center to accelerate development of its rapid COVID-19 Antigen Test

Kephera Diagnostics receives $417,074 grant award from the Massachusetts Life Sciences Center to accelerate development of its rapid COVID-19 Antigen Test

Among the four initial A.C.T.S. awardees are two companies: Framingham-based Kephera Diagnostics and Wellesley-based Virex Health; and two research hospitals: Beth Israel Deaconess Medical Center and Brigham and Women’s Hospital. ...

ByKephera Diagnostics, LLC


We proudly present: the new SURUS website!

We proudly present: the new SURUS website!

With the number of medical research papers published daily, we know it’s challenging to stay up-to-date. ...

ByMedstone Holding BV


VeriSIM Life Enters into Collaboration Agreement with Mayo Clinic to Jointly Advance Drug Discovery and Development Programs

VeriSIM Life Enters into Collaboration Agreement with Mayo Clinic to Jointly Advance Drug Discovery and Development Programs

“We are excited to expand our common mission and work with the world’s top research hospital and its drug discovery programs.” Under the terms of the collaboration agreement, VeriSIM will leverage its proprietary BIOiSIM™ platform and Translational Index™ approach to reduce the number of outsourced preclinical experiments and help ...

ByVeriSIM Life


Neutron Therapeutics and University Hospital of Brussels Announce Their Collaboration to Offer Cancer Patients a Revolutionary New Treatment Method at Institut Jules Bordet

Neutron Therapeutics and University Hospital of Brussels Announce Their Collaboration to Offer Cancer Patients a Revolutionary New Treatment Method at Institut Jules Bordet

BOSTON & BRUSSELS--(BUSINESS WIRE)--Neutron Therapeutics, Inc (NT) and the University Hospital of Brussels (H.U.B) today announced that they have signed a Letter of Intent to place a nuBeam® suite for Boron-Neutron Capture Therapy (BNCT) at the Institut Jules Bordet (IJB), Erasmus Campus, Anderlecht. nuBeam® is the world’s safest and most powerful ...

ByNeutron Therapeutics, Inc.


Neutron Therapeutics and University Hospital of Brussels Announce Their Collaboration to Offer Cancer Patients a Revolutionary New Treatment Method at Institut Jules Bordet

Neutron Therapeutics and University Hospital of Brussels Announce Their Collaboration to Offer Cancer Patients a Revolutionary New Treatment Method at Institut Jules Bordet

BOSTON & BRUSSELS--(BUSINESS WIRE)--Neutron Therapeutics, Inc (NT) and the University Hospital of Brussels (H.U.B) today announced that they have signed a Letter of Intent to place a nuBeam® suite for Boron-Neutron Capture Therapy (BNCT) at the Institut Jules Bordet (IJB), Erasmus Campus, Anderlecht. nuBeam® is the world’s safest and most powerful ...

ByNeutron Therapeutics, Inc.


Vaccine trial to investigate a booster for teenagers to protect against COVID-19

Vaccine trial to investigate a booster for teenagers to protect against COVID-19

Backed through funding from the Vaccines Taskforce and National Institute for Health Research (NIHR), the Com-COV 3 trial will seek to recruit 270 volunteers across the UK. ...

ByMediWales


TecTraum Announces Completion of Multisite Clinical Trial Using pro2cool Device for the Treatment of Concussions

TecTraum Announces Completion of Multisite Clinical Trial Using pro2cool Device for the Treatment of Concussions

“As the principal investigator in the study we are thankful for the hard work of the research team from Akron Children’s Hospital. We also appreciate the coordination and communication demonstrated in this study by all of the researchers in this multicenter ...

ByTecTraum Inc.


ABK Biomedical Announces First Patient Treated in First-in-Human Clinical Study with Eye90 microspheres™ for treatment of liver tumors

ABK Biomedical Announces First Patient Treated in First-in-Human Clinical Study with Eye90 microspheres™ for treatment of liver tumors

ABK Biomedical, Inc., an innovative, clinical-stage medical device company dedicated to the research, development and commercialization of advanced imageable embolic therapies, announced the first patient treated in ABK’s First-in-Human study with Eye90 microspheres™, a Y90 radioembolization device for the treatment of liver cancers. This study is being conducted in ...

ByABK Biomedical Inc.


Podimetrics Secures $45 Million Series C To Help At-Risk Providers and Health Plans Prevent Diabetic Amputations in High-Risk Patients

Podimetrics Secures $45 Million Series C To Help At-Risk Providers and Health Plans Prevent Diabetic Amputations in High-Risk Patients

Recent peer-reviewed research has also suggested the following benefits among patients using the SmartMat at home: 71% elimination of amputations; 52% reduction in all-cause hospitalizations; 40% reduction in emergency department visits; and a 26% reduction in outpatient visits. ...

ByPodimetrics Inc.


Deborah Heart and Lung Center Introduces the Ivenix Infusion System to the Hospital

Deborah Heart and Lung Center Introduces the Ivenix Infusion System to the Hospital

Deborah Heart and Lung Center announces its successful hospital-wide go live with Ivenix, a modern smart infusion pump system. ...

ByIvenix, Inc.


Tetra Bio-Pharma Provides Update on Research Collaboration with the University of Montreal Hospital Research Centre for Inhaled CBD

Tetra Bio-Pharma Provides Update on Research Collaboration with the University of Montreal Hospital Research Centre for Inhaled CBD

Jutras-Aswad and the University of Montreal Hospital Research Centre (Centre de recherche du Centre hospitalier de l'Université de Montréal, ("CRCHUM"). ...

ByTetra Bio-Pharma


Microbiotica raises £50 million ($67 million) to advance pipeline of microbiome-based therapeutics

Microbiotica raises £50 million ($67 million) to advance pipeline of microbiome-based therapeutics

Microbiotica has partnered with leading organisations, such as Cancer Research UK, Cambridge University Hospitals, University of Adelaide and ...

ByMicrobiotica Limited


Cellphire Therapeutics Appoints Roy A. Beveridge, M.D. to Scientific Advisory Board

Cellphire Therapeutics Appoints Roy A. Beveridge, M.D. to Scientific Advisory Board

He also served as Co-Director of Bone Marrow Transplant Program, INOVA Fairfax Hospital. Dr. Beveridge’s research has focused on oncology, stem cells and cord blood, and he is the author of more than 180 peer reviewed publications in these fields. ...

ByCellphire Therapeutics, Inc.


BlueRock Therapeutics Announces First Patient Dosed in Canada in Phase 1 Trial in Patients with Advanced Parkinson’s Disease

BlueRock Therapeutics Announces First Patient Dosed in Canada in Phase 1 Trial in Patients with Advanced Parkinson’s Disease

” About the DA01 Phase 1 Trial In Canada, the trial is being conducted in partnership with University Health Network, Canada’s largest research and teaching hospital network, located in Toronto, Ontario under the guidance of Dr. ...

ByBlueRock Therapeutics


Research Finds All-Cause Hospitalizations are Nearly Three Times More Likely During a Diabetic Foot Ulcer Episode

Research Finds All-Cause Hospitalizations are Nearly Three Times More Likely During a Diabetic Foot Ulcer Episode

The research found that during episodes-of-care for diabetic foot ulcers, individuals are 50 percent more likely to die and nearly three times more likely to be hospitalized. The peer-reviewed research was published in Diabetes Research and Clinical Practice, the journal of the International Diabetes Federation. ...

ByPodimetrics Inc.

  • Previous
  • Next
Need help finding the right suppliers?Try XPRT Sourcing. Let the XPRTs do the work for you
Back to top
About Medical XPRT

Medical XPRT is a global marketplace with solutions and suppliers for the medical sector, with product catalogs, articles, industry events, publications & more.

Channels

Solutions

  • Medical Equipment & Supplies
  • Medical Software
  • Medical Training Courses
  • Medical Industry Services
  • Medical Product Applications

Latest

  • Medical Industry News
  • Medical Industry Events

Publications

  • Medical Industry Articles & Case Studies
  • Medical Industry Books and Publications
  • Medical Industry Journals and Magazines
  • Medical Industry Downloads
  • Medical Industry Videos

Companies

  • Medical Industry Suppliers & Manufacturers

  • FAQs
  • Company sitemap
  • Category sitemap
Medical XPRT is part of XPRT Media All Rights Reserved.
Terms
Privacy
  • Medical XPRT RSS List
Our sites:
Environmental XPRT
Agriculture XPRT
Energy XPRT
XPRT